Paydirt
LB
Insider

Laura Brege

Director

Laura Brege (Director) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales), most often in ACADIA Pharmaceuticals Inc. (ACAD). The largest single filing was $1.3M of MIRM (17,000 sh across 2 lots, as filed), executed Sep 11 2025.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.6M
shares × price, as filed
Last traded
Sep 11 2025
Filed Sep 12 2025

Median ADV $83.1M across their filed names

Open performance→
Volume by month
$1.3M$632K$0Oct 2024Apr 2025Oct 2025Apr 2026Jun 2025 · sells $315KSep 2025 · sells $1.3M
Buys $0 Sells $1.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 2 filings

Sector per market data · by filing · past 24 months

Most traded names
ACAD ACADIA Pharmaceuticals Inc. ACAD · 0 buys · 1 sell 1 filing MIRM Mirum Pharmaceuticals, Inc. MIRM · 0 buys · 1 sell 1 filing
Recent filings
MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $1.3M
17,000 sh across 2 lots
Exec Sep 11 2025
Filed Sep 12 2025 · 5:30 PM ET ACADSALE ACADIA Pharmaceuticals Inc. View filing → $315K
14,446 sh × $21.78
Exec Jun 4 2025
Filed Jun 5 2025 · 5:30 PM ET